EU's UPC grants Abbott preliminary injunction against Sibionics’ glucose monitor
By Inbar Preiss ( February 20, 2025, 15:33 GMT | Insight) -- Abbott Diabetes Care Inc. secured a preliminary injunction from the UPC Court of Appeal, blocking Sibionics from selling its GS1 continuous glucose monitor in multiple European countries. The appellate court overturned a prior decision denying the injunction, finding Abbott’s patent likely valid and infringed. While the court upheld Abbott’s enforcement rights across UPC member states, it rejected its request to extend the injunction to Ireland.Abbott Diabetes Care Inc. was granted a preliminary injunction against Sibionics at the EU's Unified Patent Court....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.